
Make Inhaled Treatments Accessible for ALL
- 17 May 25
- 192 revirew
- 0 comment
World Asthma Day, supported by Global Initiative for Asthma (GINA), has been observed annually for the past ten years on the first Tuesday of May. The day raise awareness about asthma and its impact on individuals and their families.
Asthma is a chronic lung condition that leads to breathing difficulties due to the inflammation and swelling of the bronchial tubes. Although asthma cannot typically be cured, it can be managed effectively with the right medications and lifestyle adjustments. If controlled, individuals with asthma can lead relatively normal lives, although they must often avoid certain triggers. Asthma is one of the most prevalent chronic non-communicable diseases, affecting over 260 million people globally and causing more than 450,000 deaths each year. Most of these fatalities are preventable.
World Asthma Day features an annual theme and according to GINA, the 2025 theme revolves around: “Make Inhaled Treatments Accessible for ALL.” It highlights the necessity of ensuring that everyone with asthma can access crucial inhaled medications, especially inhaled corticosteroids that help manage the disease and prevent attacks.
In low- and middle-income countries, barriers such as high costs and limited availability of inhaled medications contribute to the staggering statistic that 96% of global asthma deaths occur in these areas.
Over the past 34 years, MAHAK Charity Institute has cared for 278 children facing both cancer and asthma simultaneously. Among them, 76 have recovered and now are living normal lives just like their peers.
Recognizing the importance of education and understanding in asthma management, MAHAK Charity Institute has always strived to promote awareness upon asthma aiming to improve access to asthma treatments and reduce the morbidity and mortality associated with this disease.
Despite ongoing sanctions and limitations, MAHAK remains dedicated to providing the best possible medications for children dealing with cancer and will continue to do so.
